Incretins are the newest and most expensive class of blockbuster diabetes drug but according to a remarkably through investigation just published by the BMJ (British Medical Journal)  the risk that they could cause pancreatic cancer is much greater than patients and doctors have been told. The biggest sellers in the UK are Byetta (exenatide),  Victoza […]